Bloomage Biotech

Forecast & Rating9 analysts currently cover Bloomage Biotech, with about 33.3% giving a positive rating — meaning they expect the stock to rise. The average price target is ¥39.70, about 2.1% upside from the current price of ¥38.90. Price targets range from ¥25.00 to ¥60.00 — a wide spread, showing clear disagreement over just how much Bloomage Biotech can rise. Historically, about 36.9% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Bloomage Biotech's outlook. Data as of Jul 27, 2026; for reference only and not investment advice.